Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (17) , 4187-4191
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteinsTrends in Biochemical Sciences, 2011
- Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer diseaseExpert Reviews in Molecular Medicine, 2011
- FAK Phosphorylation by ERK Primes Ras-Induced Tyrosine Dephosphorylation of FAK Mediated by PIN1 and PTP-PESTMolecular Cell, 2009
- The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancerNature Cell Biology, 2009
- Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for CancerCurrent Cancer Drug Targets, 2008
- Pinning Down Signaling in the Immune System: The Role of the Peptidyl-Prolyl Isomerase Pin1 in Immune Cell FunctionCritical Reviews in Immunology, 2008
- Molecular mechanisms of the phospho‐dependent prolyl cis/trans isomerase Pin1The FEBS Journal, 2007
- PIN1, the cell cycle and cancerNature Reviews Cancer, 2007
- Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism2000
- A human peptidyl–prolyl isomerase essential for regulation of mitosisNature, 1996